secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K
Filed at:   2022-11-08T23:59:59+00:00
Accession:  0001818093-22-000166
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeautyHealth Q3 net sales $88.8M (+30% YoY), raises FY net sales guidance; cuts EBITDA outlook
--------------------------------------------------------------------------------

- Net sales $88.8M (+30% YoY), seventh consecutive beat; raised FY2022 net sales guidance to $360-365M.
- GAAP net income $0.1M vs loss $215.1M a year ago; adjusted net income $8.0M.
- Adjusted EBITDA $16.5M (18.6% margin); FY2022 adjusted EBITDA guidance revised to $45-50M due to FX and China zero-COVID.
- Americas net sales $58.4M (+30% YoY); APAC $15.1M (+44%); EMEA $15.3M (+21%).
- Year-to-date delivery systems sold (6,447) already exceed full-year 2021 record of 6,191; total install base 24,473.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000181809322000166/0001818093-22-000166-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000181809322000166/skin-20221108.htm
  HTML page:      https://secwatch.observer/filing/0001818093-22-000166

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer